Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I chloroquine added to chemoradiation for newly diagnosed glioblastoma
NL-OMON44953Phase 1Active, not recruiting
- Sponsor
- Maastro Clinic
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of chloroquine in glioblastoma (GBM) (5 cohorts), sponsored by Maastro Clinic. Primary endpoint: Incidence of dose-limiting toxicities. Started Sep 2016; status: active, not recruiting.
02
Drugs
chloroquine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NL-OMON44953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44953.